Carbonate prodrugs and methods of using the same
AssigneeAcorda Therapeutics, Inc.
InventorsNaweed Muhammad, Keith R. Bley
Life of this patent
Estimating the term…
Abstract
The present invention provides carbonate prodrugs which comprise a carbonic phosphoric anhydride prodrug moiety attached to the hydroxyl or carboxyl group of a parent drug moiety. The prodrugs may provide improved physicochemical properties over the parent drug. Also provided are methods of treating a disease or condition that is responsive to the parent drug using the carbonate prodrugs, as well as kits and unit dosages.
Claims13
A method of treating a disease or condition that is responsive to a parent drug, the method comprising administering to an individual an effective amount of a prodrug, wherein the prodrug comprises:
- (a) a moiety of parent drug, wherein the parent drug comprises a hydroxyl group or a carboxyl group;
- and
- (b) a prodrug moiety of the formula:
- wherein the prodrug moiety is bound to the moiety of the parent drug at the hydroxyl or carboxyl group providing a carbonate moiety;
- or a pharmaceutically acceptable salt thereof or solvate of the foregoing.
Dependencies are inferred from the claim text.